Literature DB >> 25177084

Transjugular Intrahepatic Portosystemic Shunt before and after Liver Transplantation.

Wael E Saad1.   

Abstract

The transjugular intrahepatic portosystemic shunt (TIPS) has long been referred to as a procedure performed as "a bridge to transplantation" since, like many other portosystemic shunts, it decompresses the portal circulation and stabilizes patients but does not definitively treat portal hypertension. One of the major advantages of TIPS over surgically placed portosystemic shunts in the transplant era is that the TIPS is intrahepatic and is removed in situ with the native liver, and usually does not need additional surgery (unlike takedown/ligation of surgical shunts). There are several studies that evaluate TIPS before transplantation-not as a bridge/temporizing measure, but as a prelude to the transplant to decompress the portal circulation and reduce portosystemic engorgement and collaterals and thus, in theory, reduce intraoperative bleeding during liver transplantation. However, these studies, mostly in the transplant literature, have been equivocal from an intraoperative and posttransplant clinical outcome standpoint. TIPS creation in liver transplant recipients is another interesting aspect of TIPS. There has been a debate about whether or not liver transplantation adds additional technical difficulty to the TIPS procedure. Initially, many theories were proposed as to the technical difficulty of TIPS in a transplanted liver. However, recent opinions and published studies demonstrate that whole-graft liver transplantation does not pose a significant technical difficulty to TIPS. Moreover, there are several recent studies evaluating the outcomes of TIPS in liver transplant recipients, showing that outcomes are less favorable when compared with TIPS in nontransplanted patients. This article discusses the results of TIPS as a preoperative prelude to liver transplantation. In addition, it discusses the technical and clinical outcomes of TIPS in liver transplant recipients.

Entities:  

Keywords:  TIPS; liver transplantation; portal hypertension

Year:  2014        PMID: 25177084      PMCID: PMC4139429          DOI: 10.1055/s-0034-1382791

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  40 in total

1.  Blood conservation in liver transplantation: The role of aprotinin.

Authors:  Robert J Porte; Herman G d Hendriks; Maarten J h Slooff
Journal:  J Cardiothorac Vasc Anesth       Date:  2004-08       Impact factor: 2.628

2.  Effect of a prior portasystemic shunt on subsequent liver transplantation.

Authors:  J J Brems; J R Hiatt; A S Klein; J M Millis; J O Colonna; W J Quinones-Baldrich; K P Ramming; R W Busuttil
Journal:  Ann Surg       Date:  1989-01       Impact factor: 12.969

3.  Transjugular intrahepatic portosystemic shunts: impact on liver transplantation.

Authors:  J M Millis; P Martin; A Gomes; A Shaked; S D Colquhoun; O Jurim; L Goldstein; R W Busuttil
Journal:  Liver Transpl Surg       Date:  1995-07

4.  Transjugular intrahepatic portosystemic shunt in a living donor left lateral segment liver transplant recipient: technical considerations.

Authors:  Wael E A Saad; Mark G Davies; David E Lee; Nikhil C Patel; Lawrence G Sahler; Talia Sasson; Takashi Kitanososno; David L Waldman
Journal:  J Vasc Interv Radiol       Date:  2005-06       Impact factor: 3.464

5.  Elective transjugular intrahepatic portosystemic shunt creation for portal decompression in the immediate pretransplantation period in adult living related liver transplant recipient candidates: preliminary results.

Authors:  Wael E A Saad; Nael E A Saad; Mark G Davies; Adel Bozorgdadeh; Mark S Orloff; Nikhil C Patel; Peter L Abt; David E Lee; Lawrence G Sahler; Takashi Kitanosono; Talia Sasson; David L Waldman
Journal:  J Vasc Interv Radiol       Date:  2006-06       Impact factor: 3.464

6.  Multiple organ failure after liver transplantation.

Authors:  T B Spanier; R D Klein; S A Nasraway; W M Rand; R J Rohrer; R B Freeman; S D Schwaitzberg
Journal:  Crit Care Med       Date:  1995-03       Impact factor: 7.598

7.  Transjugular intrahepatic portosystemic shunt and liver transplantation.

Authors:  J P Lerut; P F Laterre; P Goffette; O Cicarelli; M Donataccio; D Mazza; T Puttemans; M Mourad; M S Reynaert; A Geubel; J B Otte
Journal:  Transpl Int       Date:  1996       Impact factor: 3.782

8.  Live donor liver transplantation without blood products: strategies developed for Jehovah's Witnesses offer broad application.

Authors:  Nicolas Jabbour; Singh Gagandeep; Rodrigo Mateo; Linda Sher; Earl Strum; John Donovan; Jeffrey Kahn; Christian G Peyre; Randy Henderson; Tse-Ling Fong; Rick Selby; Yuri Genyk
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

9.  Transjugular intrahepatic portosystemic shunt in liver transplant recipients.

Authors:  Armin Finkenstedt; Ivo W Graziadei; Karin Nachbaur; Werner Jaschke; Walter Mark; Raimund Margreiter; Wolfgang Vogel
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

10.  Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them.

Authors:  Emilio Ramos; Antonia Dalmau; Antonio Sabate; Carmen Lama; Laura Llado; Juan Figueras; Eduardo Jaurrieta
Journal:  Liver Transpl       Date:  2003-12       Impact factor: 5.799

View more
  2 in total

1.  Implantability, Complications, and Follow-Up After Transjugular Intrahepatic Portosystemic Stent-Shunt Creation With the 6F Self-Expanding Sinus-SuperFlex-Visual Stent.

Authors:  Daniel Spira; Jakub Wiskirchen; Ulrich Lauer; Dominik Ketelsen; Konstantin Nikolaou; Benjamin Wiesinger
Journal:  Iran J Radiol       Date:  2016-02-17       Impact factor: 0.212

2.  Gastroesophageal Variceal Bleeding Successfully Controlled by Partial Splenic Embolization.

Authors:  Takayuki Kogure; Jun Inoue; Eiji Kakazu; Masashi Ninomiya; Tooru Shimosegawa
Journal:  Intern Med       Date:  2017-06-01       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.